Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03856060 · ClinicalTrials.gov registry record · NA

Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits

A NA study of Malignant Neoplasm and Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT03856060: Completed NA study of Malignant Neoplasm and Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.

NCT03856060 is a NA study of Malignant Neoplasm and Advanced Malignant Neoplasm that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 125 participants, below the 511-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03856060, a NA study of Malignant Neoplasm and Advanced Malignant Neoplasm, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This trial assesses patient perception of physician's compassion, communication skills, and professionalism during clinic visits through the use of videos and questionnaires.

Primary Outcome

Quantified by the total score of ratings from a comprehensive 5-item tool which assesses dimensions such as warm/cold, pleasant/unpleasant, compassionate/distant, sensitive/insensitive, and caring/uncaring (ranging from 0 to 10 for each item, and from 0 to 50 for the total score). Physicians' compassion, communication skills and professionalism will be compared between standard electronic health record (EHR) and integrated EHR groups at the end of each video using a two-sample t-test or Wilcoxon

Interventions

  • OTHER Questionnaire Administration
  • OTHER Video

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2019-03-30
Est. Completion 2024-08-30
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT03856060 record still lists

NCT03856060 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 511-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (76% lower).

The record links to 5 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT03856060 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03856060 about?

NCT03856060 is a clinical study titled "Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits". This trial assesses patient perception of physician's compassion, communication skills, and professionalism during clinic visits through the use of videos and questionnaires.

What is the current status of trial NCT03856060?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2019-03-30. Estimated completion is 2024-08-30.

What conditions does trial NCT03856060 study?

This clinical trial studies the following conditions: Malignant Neoplasm, Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Locally Advanced Malignant Neoplasm, Recurrent Malignant Neoplasm.

What interventions are being tested in trial NCT03856060?

The interventions under investigation include: Questionnaire Administration (OTHER), Video (OTHER).

Who is sponsoring clinical trial NCT03856060?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03856060 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03856060's enrollment target sits among peer trials

125 28th of 59 higher than 32 of 59 other Malignant Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03856060, the US trial registry maintained by the National Library of Medicine. NCT03856060 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.